scholarly journals S117 4 h cough frequency monitoring with the Leicester Cough Monitor

Thorax ◽  
2010 ◽  
Vol 65 (Suppl 4) ◽  
pp. A54-A54 ◽  
Author(s):  
K. K. Lee ◽  
A. Savani ◽  
S. Matos ◽  
C. Woods ◽  
I. D. Pavord ◽  
...  
CHEST Journal ◽  
2012 ◽  
Vol 142 (5) ◽  
pp. 1237-1243 ◽  
Author(s):  
Kai K. Lee ◽  
Alka Savani ◽  
Sergio Matos ◽  
David H. Evans ◽  
Ian D. Pavord ◽  
...  

Author(s):  
Kai K. Lee ◽  
Sergio Matos ◽  
David H. Evans ◽  
Ian D. Pavord ◽  
Surinder S. Birring

2021 ◽  
pp. 00319-2021
Author(s):  
Anne E. Vertigan ◽  
Sarah L. Kapela ◽  
Surinder S. Birring ◽  
Peter G. Gibson

Research questionObjective quantification of cough is rarely utilised outside of research settings and the role of cough frequency monitoring in clinical practice has not been established. This study examined the clinical utility of cough frequency monitoring in an outpatient clinical setting.MethodsThe study involved a retrospective review of cough monitor data. Participants included 174 patients referred for treatment of cough and upper airway symptoms (103 chronic cough; 50 inducible laryngeal obstruction; 21 severe asthma), and 15 controls. Measures, taken prior to treatment, included 24-h ambulatory cough frequency using the Leicester Cough Monitor, the Leicester Cough Questionnaire and Laryngeal Hypersensitivity Questionnaire. Post-treatment data was available for 50 participants. Feasibility and clinical utility were also reported.ResultsAnalysis time per recording was up to 10 min. Seventy five percent of participants could use the monitors correctly and most (93%) recordings were interpretable. The geometric mean cough frequency in patients was 10.1 (sd=2.9) compared to 2.4 (2.0) for healthy controls, (p=0.003). There was no significant difference in cough frequency between clinical groups, (p=0.080). Cough frequency decreased significantly following treatment, (p<0.001). There was a moderate correlation between cough frequency and both cough quality of life and laryngeal hypersensitivity. Cough frequency monitoring was responsive to therapy, and able to discriminate differences in cough frequency between diseases.ConclusionWhile ambulatory cough frequency monitoring remains a research tool, it provides useful clinical data that can assist in patient management. Logistical issues may preclude use in some clinical settings and additional time needs to be allocated to the process.


Thorax ◽  
2014 ◽  
Vol 69 (Suppl 2) ◽  
pp. A80-A81 ◽  
Author(s):  
A. Spinou ◽  
R. Garrod ◽  
K. Lee ◽  
C. Elston ◽  
M. Loebinger ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Takehiro Otoshi ◽  
Tatsuya Nagano ◽  
Shintaro Izumi ◽  
Daisuke Hazama ◽  
Naoko Katsurada ◽  
...  

AbstractObjective evaluations of cough frequency are considered important for assessing the clinical state of patients with respiratory diseases. However, cough monitors with audio recordings are rarely used in clinical settings. Issues regarding privacy and background noise with audio recordings are barriers to the wide use of these monitors; to solve these problems, we developed a novel automatic cough frequency monitoring system combining a triaxial accelerator and a stretchable strain sensor. Eleven healthy adult volunteers and 10 adult patients with cough were enrolled. The participants wore two devices for 30 min for the cough measurements. An accelerator was attached to the epigastric region, and a stretchable strain sensor was worn around their neck. When the subjects coughed, these devices displayed specific waveforms. The data from all the participants were categorized into a training dataset and a test dataset. Using a variational autoencoder, a machine learning algorithm with deep learning, the components of the test dataset were automatically judged as being a “cough unit” or “non-cough unit”. The sensitivity and specificity in detecting coughs were 92% and 96%, respectively. Our cough monitoring system has the potential to be widely used in clinical settings without any concerns regarding privacy or background noise.


2021 ◽  
Vol 7 (4) ◽  
pp. 00545-2021
Author(s):  
Ji-Hyang Lee ◽  
Woo-Jung Song ◽  
Eva Millqvist ◽  
Alyn H. Morice

2020 ◽  
Author(s):  
Takehiro Otoshi ◽  
Tatsuya Nagano ◽  
Shintaro Izumi ◽  
Daisuke Hazama ◽  
Naoko Katsurada ◽  
...  

Abstract BackgroundObjective evaluations of cough frequency are considered important for assessing the clinical state of patients with respiratory diseases. While cough monitors with audio recordings are used in research settings, they are rarely used in clinical settings. Issues regarding privacy and background noise (especially the sounds of someone else’s cough) with audio recordings are barriers to the wide use of these monitors in clinical settings; to solve these problems, we developed a novel automatic cough frequency monitoring system combining a triaxial accelerator and a stretchable strain sensor.MethodsEleven healthy adult volunteers and 10 adult patients with cough were enrolled. The participants sat in a chair and wore two devices for 30 minutes for the cough measurements. An accelerator was attached to the epigastric region, and a stretchable strain sensor was worn around their neck. When the subjects coughed, these devices displayed specific waveforms. For the development of the algorithm, the participants’ measurement data from both devices were divided into consecutive small “units” lasting 5 seconds each. Whether each unit corresponded to a “cough unit” was determined by the observer who manually counted the cough records. Then, the data from all the participants were categorized into a training dataset and a test dataset. Using a variational autoencoder, a machine learning algorithm with deep learning, the components of the test dataset were automatically judged as being a “cough unit” or “non-cough unit”.ResultsThe sensitivity and specificity in detecting coughs among 21 participants were 92% and 96%, respectively. The triaxial accelerometer only yielded a sensitivity of 91% and specificity of 95%. Therefore, the diagnostic accuracy improved slightly when the accelerometer was combined with a stretchable strain sensor.ConclusionsAccording to the results of the current study, a cough frequency monitor with good performance can be created by combining an accelerometer and another biometric sensor. Our cough monitor is suitable for ambulatory settings because the devices are small and light. Our cough monitoring system, which does not require audio recordings, has the potential to be widely used in clinical settings without any concerns regarding privacy or background noise.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Weigang Jia ◽  
Wei Wang ◽  
Rui Li ◽  
Quanyu Zhou ◽  
Ying Qu ◽  
...  

Abstract Background In recent years, it has been reported that Qinbai Qingfei Concentrated Pellet (QQCP) has the effect of relieving cough and reducing sputum. However, the therapeutic potentials of QQCP on post-infectious cough (PIC) rat models has not been elucidated. So the current study was aimed to scientifically validate the efficacy of QQCP in post infectious cough. Methods All rats were exposed to sawdust and cigarette smokes for 10 days, and intratracheal lipopolysaccharide (LPS) and capsaicin aerosols. Rats were treated with QQCP at dose of 80, 160, 320 mg/kg. Cough frequency was monitored twice a day for 10 days after drug administration. Inflammatory cell infiltration was determined by ELISA. Meanwhile, the histopathology of lung tissue and bronchus in rats were evaluated by hematoxylin-eosin staining (H&E). Neurogenetic inflammation were measured by ELISA and qRT-PCR. Results QQCP dose-dependently decreased the cough frequency and the release of pro-inflammatory cytokines TNF-α, IL-1β, IL-6 and IL-8, but exerted the opposite effects on the secretion of anti-inflammatory cytokines IL-10 and IL-13 in BALF and serum of PIC rats. The oxidative burden was effectively ameliorated in QQCP-treated PIC rats as there were declines in Malondialdehyde (MDA) content and increases in Superoxide dismutase (SOD) activity in the serum and lung tissue. In addition, QQCP blocked inflammatory cell infiltration into the lung as evidenced by the reduced number of total leukocytes and the portion of neutrophils in the broncho - alveolar lavage fluid (BALF) as well as the alleviated lung damage. Furthermore, QQCP considerable reversed the neurogenetic inflammation caused by PIC through elevating neutral endopeptidase (NEP) activity and reducing Substance P (SP) and Calcitonin gene related peptide (CGRP) expression in BALF, serum and lung tissue. Conclusions Our study indicated that QQCP demonstrated a protective role of PIC and may be a potential therapeutic target of PIC.


Sign in / Sign up

Export Citation Format

Share Document